197 related items for PubMed ID: 19052341
1. Rational use of glucocorticoid during pituitary surgery--a pilot study.
Bhansali A, Dutta P, Bhat MH, Mukherjee KK, Rajput R, Bhadada S.
Indian J Med Res; 2008 Sep; 128(3):294-9. PubMed ID: 19052341
[Abstract] [Full Text] [Related]
2. Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary.
Wentworth JM, Gao N, Sumithran KP, Maartens NF, Kaye AH, Colman PG, Ebeling PR.
Clin Endocrinol (Oxf); 2008 Jan; 68(1):29-35. PubMed ID: 18088287
[Abstract] [Full Text] [Related]
3. Peri-operative glucocorticoid replacement therapy in transsphenoidal pituitary adenoma surgery: a prospective controlled study.
Kristof RA, Wichers M, Haun D, Redel L, Klingmüller D, Schramm J.
Acta Neurochir (Wien); 2008 Apr; 150(4):329-35; discussion 335. PubMed ID: 18309452
[Abstract] [Full Text] [Related]
4. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.
McLaughlin N, Cohan P, Barnett P, Eisenberg A, Chaloner C, Kelly DF.
World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358
[Abstract] [Full Text] [Related]
5. Evaluation of the hypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary?
Hout WM, Arafah BM, Salazar R, Selman W.
J Clin Endocrinol Metab; 1988 Jun; 66(6):1208-12. PubMed ID: 3372683
[Abstract] [Full Text] [Related]
6. Transphenoidal surgery without steroid replacement in patients with morning serum cortisol below 9 μg/dl (250 Nmol/l).
De Tommasi C, Goguen J, Cusimano MD.
Acta Neurochir (Wien); 2012 Oct; 154(10):1903-15. PubMed ID: 22922981
[Abstract] [Full Text] [Related]
7. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis.
Courtney CH, McAllister AS, McCance DR, Bell PM, Hadden DR, Leslie H, Sheridan B, Atkinson AB.
Clin Endocrinol (Oxf); 2000 Oct; 53(4):431-6. PubMed ID: 11012567
[Abstract] [Full Text] [Related]
8. Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease.
Rollin GA, Ferreira NP, Junges M, Gross JL, Czepielewski MA.
J Clin Endocrinol Metab; 2004 Mar; 89(3):1131-9. PubMed ID: 15001598
[Abstract] [Full Text] [Related]
9. [Selective use of glucocorticoids during the perioperative period of transsphenoidal surgery for pituitary tumors].
Carrasco CA, Villanueva G P.
Rev Med Chil; 2014 Sep; 142(9):1113-9. PubMed ID: 25517050
[Abstract] [Full Text] [Related]
10. Can basal cortisol measurement be an alternative to the insulin tolerance test in the assessment of the hypothalamic-pituitary-adrenal axis before and after pituitary surgery?
Karaca Z, Tanriverdi F, Atmaca H, Gokce C, Elbuken G, Selcuklu A, Unluhizarci K, Kelestimur F.
Eur J Endocrinol; 2010 Sep; 163(3):377-82. PubMed ID: 20530552
[Abstract] [Full Text] [Related]
11. Use of day 1 early morning cortisol to predict the need for glucocorticoid replacement after pituitary surgery.
Bondugulapati LN, Campbell C, Chowdhury SR, Goetz P, Davies JS, Rees DA, Hayhurst C.
Br J Neurosurg; 2016 Sep; 30(1):76-9. PubMed ID: 26313503
[Abstract] [Full Text] [Related]
12. Plasma cortisol response to 1-24 adrenocorticotropin in patients with treated/untreated sellar & suprasellar mass lesions.
Bhansali A, Sreenivasulu P, Subrahmanyam KA, Sharma BR, Dash RJ.
Indian J Med Res; 2004 May; 119(5):190-4. PubMed ID: 15218981
[Abstract] [Full Text] [Related]
13. Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation.
Marko NF, Gonugunta VA, Hamrahian AH, Usmani A, Mayberg MR, Weil RJ.
J Neurosurg; 2009 Sep; 111(3):540-4. PubMed ID: 19326985
[Abstract] [Full Text] [Related]
14. UTILITY OF A GLUCOCORTICOID SPARING STRATEGY IN THE MANAGEMENT OF PATIENTS FOLLOWING TRANSSPHENOIDAL SURGERY.
Jia X, Pendharkar AV, Loftus P, Dodd RL, Chu O, Fraenkel M, Katznelson L.
Endocr Pract; 2016 Sep; 22(9):1033-9. PubMed ID: 27124693
[Abstract] [Full Text] [Related]
15. Recovery Room Cortisol Predicts Long-Term Glucocorticoid Need After Transsphenoidal Surgery for Pituitary Tumors.
Qaddoura A, Shalung TN, Meier MP, Goguen J, Jing R, Zhang S, Kovacs K, Cusimano MD.
Neurosurgery; 2019 Mar 01; 84(3):616-623. PubMed ID: 30767017
[Abstract] [Full Text] [Related]
16. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ, Martino J, Masuet C, Montanya E, Soler J.
Acta Neurochir (Wien); 2007 Mar 01; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[Abstract] [Full Text] [Related]
17. Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?
Auchus RJ, Shewbridge RK, Shepherd MD.
Clin Endocrinol (Oxf); 1997 Jan 01; 46(1):21-7. PubMed ID: 9059554
[Abstract] [Full Text] [Related]
18. Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors.
Jayasena CN, Gadhvi KA, Gohel B, Martin NM, Mendoza N, Meeran K, Dhillo WS.
Clin Chem; 2009 May 01; 55(5):972-7. PubMed ID: 19282356
[Abstract] [Full Text] [Related]
19. Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively.
Pimentel-Filho FR, Silva ME, Nogueira KC, Berger K, Cukiert A, Liberman B.
J Endocrinol Invest; 2005 Jun 01; 28(6):502-8. PubMed ID: 16117190
[Abstract] [Full Text] [Related]
20. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
Agha A, Liew A, Finucane F, Baker L, O'Kelly P, Tormey W, Thompson CJ.
Clin Endocrinol (Oxf); 2004 Jun 01; 60(6):688-93. PubMed ID: 15163331
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
